Cargando…
Discordance Between Prolactinoma Size and Prolactin Level: An Unusual Laboratory Finding
Background: Prolactinomas are a common cause of hyperprolactinemia. Prolactin (PRL) level higher than 250 mcg/L is associated with a prolactinoma and serum prolactin levels generally correlate with tumor size. It is unusual to find a PRL level that is markedly elevated out of proportion to prolactin...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090658/ http://dx.doi.org/10.1210/jendso/bvab048.1187 |
_version_ | 1783687336353071104 |
---|---|
author | Dawaher, Wafa Patel, Sabah Unjom, Zubina Moid, Alvia Gilden, Janice L Trendafilova, Victoria |
author_facet | Dawaher, Wafa Patel, Sabah Unjom, Zubina Moid, Alvia Gilden, Janice L Trendafilova, Victoria |
author_sort | Dawaher, Wafa |
collection | PubMed |
description | Background: Prolactinomas are a common cause of hyperprolactinemia. Prolactin (PRL) level higher than 250 mcg/L is associated with a prolactinoma and serum prolactin levels generally correlate with tumor size. It is unusual to find a PRL level that is markedly elevated out of proportion to prolactinoma size. We present the case of a 32-year-old man who was referred to Endocrinology Clinic with fatigue and low testosterone, found to have a PRL level of 1302 mcg/L with a 9 x 8 x 9 mm microprolactinoma. Clinical Case: A 32-year-old man with past medical history of migraines reported fatigue, weight gain, low libido and erectile dysfunction and was referred to Endocrinology Clinic due to PRL elevation. His medications included a multivitamin and chasteberry herbal supplement. Physical exam was unremarkable and no visual field abnormalities were detected. Baseline lab results showed PRL: >1000 mcg/L and 1302 mcg/L after serial dilutions, FSH: 1.8 mIU/mL [0.7- 10.8 mIU/ml], LH:0.9 L [1.2- 10.6 mIU/ml], total testosterone 136 ng/dL [250-1100 ng/dl], free testosterone: 32 [35- 155 pg/ml], with normal cortisol, ACTH, IGF-1, TSH and Free T4 levels. MRI pituitary revealed a 9 mm x 8 mm x 9 mm microadenoma on the right side of the pituitary gland without optic chiasm compression. He was diagnosed with microprolactinoma, with very high PRL level causing secondary hypogonadism. Cabergoline 0.25 mg twice weekly resulted in significant improvement in PRL level. With dose increment to 0.5 mg twice weekly, PRL level improved further along with improvement in symptoms related to hypogonadism. Five months after initiation of treatment, total PRL was 58 ng/mL with monomeric PRL of 41 mcg/L, indicating only trace contribution of macroprolactin to the total PRL level. Review of the Literature: In a retrospective study by Colao et al. (2003), men with hyperprolactinemia due to micro-prolactinoma had average pre-treatment PRL levels of 187.7 mcg/L (SD 51.8 mcg/L) and average pre-treatment diameter of 8.0 mm (SD 1.4 mm). A retrospective study of 1234 patients by Vilar et al. (2008) reported similar findings: microprolactinomas had average baseline PRL of 165.6 mcg/L (SD 255.1 mcg/L) and the highest reported level of PRL due to microprolactinoma was 525 mcg/L. Conclusion: Our case illustrates that assumptions about prolactinoma size should not be made based on laboratory findings alone. References: Melmed S. et al, Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 96: 273-288, 2011.Colao A. et al. Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia. European Journal of Endocrinology 148: 325-331.Vilar L. et al. Diagnosis and Management of Hyperprolactinemia: Results of a Brazilian Multicenter Study with 1234 Patients. J Endocrinol Invest 31:436-444. |
format | Online Article Text |
id | pubmed-8090658 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-80906582021-05-12 Discordance Between Prolactinoma Size and Prolactin Level: An Unusual Laboratory Finding Dawaher, Wafa Patel, Sabah Unjom, Zubina Moid, Alvia Gilden, Janice L Trendafilova, Victoria J Endocr Soc Neuroendocrinology and Pituitary Background: Prolactinomas are a common cause of hyperprolactinemia. Prolactin (PRL) level higher than 250 mcg/L is associated with a prolactinoma and serum prolactin levels generally correlate with tumor size. It is unusual to find a PRL level that is markedly elevated out of proportion to prolactinoma size. We present the case of a 32-year-old man who was referred to Endocrinology Clinic with fatigue and low testosterone, found to have a PRL level of 1302 mcg/L with a 9 x 8 x 9 mm microprolactinoma. Clinical Case: A 32-year-old man with past medical history of migraines reported fatigue, weight gain, low libido and erectile dysfunction and was referred to Endocrinology Clinic due to PRL elevation. His medications included a multivitamin and chasteberry herbal supplement. Physical exam was unremarkable and no visual field abnormalities were detected. Baseline lab results showed PRL: >1000 mcg/L and 1302 mcg/L after serial dilutions, FSH: 1.8 mIU/mL [0.7- 10.8 mIU/ml], LH:0.9 L [1.2- 10.6 mIU/ml], total testosterone 136 ng/dL [250-1100 ng/dl], free testosterone: 32 [35- 155 pg/ml], with normal cortisol, ACTH, IGF-1, TSH and Free T4 levels. MRI pituitary revealed a 9 mm x 8 mm x 9 mm microadenoma on the right side of the pituitary gland without optic chiasm compression. He was diagnosed with microprolactinoma, with very high PRL level causing secondary hypogonadism. Cabergoline 0.25 mg twice weekly resulted in significant improvement in PRL level. With dose increment to 0.5 mg twice weekly, PRL level improved further along with improvement in symptoms related to hypogonadism. Five months after initiation of treatment, total PRL was 58 ng/mL with monomeric PRL of 41 mcg/L, indicating only trace contribution of macroprolactin to the total PRL level. Review of the Literature: In a retrospective study by Colao et al. (2003), men with hyperprolactinemia due to micro-prolactinoma had average pre-treatment PRL levels of 187.7 mcg/L (SD 51.8 mcg/L) and average pre-treatment diameter of 8.0 mm (SD 1.4 mm). A retrospective study of 1234 patients by Vilar et al. (2008) reported similar findings: microprolactinomas had average baseline PRL of 165.6 mcg/L (SD 255.1 mcg/L) and the highest reported level of PRL due to microprolactinoma was 525 mcg/L. Conclusion: Our case illustrates that assumptions about prolactinoma size should not be made based on laboratory findings alone. References: Melmed S. et al, Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 96: 273-288, 2011.Colao A. et al. Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia. European Journal of Endocrinology 148: 325-331.Vilar L. et al. Diagnosis and Management of Hyperprolactinemia: Results of a Brazilian Multicenter Study with 1234 Patients. J Endocrinol Invest 31:436-444. Oxford University Press 2021-05-03 /pmc/articles/PMC8090658/ http://dx.doi.org/10.1210/jendso/bvab048.1187 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Neuroendocrinology and Pituitary Dawaher, Wafa Patel, Sabah Unjom, Zubina Moid, Alvia Gilden, Janice L Trendafilova, Victoria Discordance Between Prolactinoma Size and Prolactin Level: An Unusual Laboratory Finding |
title | Discordance Between Prolactinoma Size and Prolactin Level: An Unusual Laboratory Finding |
title_full | Discordance Between Prolactinoma Size and Prolactin Level: An Unusual Laboratory Finding |
title_fullStr | Discordance Between Prolactinoma Size and Prolactin Level: An Unusual Laboratory Finding |
title_full_unstemmed | Discordance Between Prolactinoma Size and Prolactin Level: An Unusual Laboratory Finding |
title_short | Discordance Between Prolactinoma Size and Prolactin Level: An Unusual Laboratory Finding |
title_sort | discordance between prolactinoma size and prolactin level: an unusual laboratory finding |
topic | Neuroendocrinology and Pituitary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090658/ http://dx.doi.org/10.1210/jendso/bvab048.1187 |
work_keys_str_mv | AT dawaherwafa discordancebetweenprolactinomasizeandprolactinlevelanunusuallaboratoryfinding AT patelsabah discordancebetweenprolactinomasizeandprolactinlevelanunusuallaboratoryfinding AT unjomzubina discordancebetweenprolactinomasizeandprolactinlevelanunusuallaboratoryfinding AT moidalvia discordancebetweenprolactinomasizeandprolactinlevelanunusuallaboratoryfinding AT gildenjanicel discordancebetweenprolactinomasizeandprolactinlevelanunusuallaboratoryfinding AT trendafilovavictoria discordancebetweenprolactinomasizeandprolactinlevelanunusuallaboratoryfinding |